MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$46,892K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable debt se...
Proceeds from atm offering
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Purchases of marketable debt sec...
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-
-
-80,751
-232,012
Net loss from continuing operations
-57,321
-76,059
-
-
Depreciation and amortization
12,315
12,799
13,663
45,327
Stock-based compensation
7,595
15,853
21,027
60,519
Goodwill impairment
-
-
0
0
Restructuring related impairment charges
-
-
0
-
Impairment of right-of-use asset
-
-
-
0
Non-cash customer consideration
-
-
0
-
(gain) loss on investments
1,987
-939
-
-275
Loss on equity method investment
-4,673
-
0
-
Loss on deconsolidation of subsidiary
-
-
-
0
Loss on investments
-
-
-16,411
-
Change in fair value of notes receivable
0
-6,759
11,370
-5,685
Change in fair value of warrant liabilities
-
-
0
0
Change in fair value of contingent consideration
0
0
0
4,232
Loss on deconsolidation of subsidiaries
-
-
0
-
Impairment of long-lived assets
-
-
0
-
Deferred income tax benefit
-
-
-1,364
-
Loss on disposal of equipment
-
-
0
-
Non-cash lease expense
6,143
7,114
7,633
22,449
Non-cash in-process research and development
-
-
0
0
Accretion of discount on marketable securities
-29
120
888
2,502
Other non-cash activity
474
-185
-453
-1,611
Changes in operating assets and liabilities
-3,713
242
1,818
-345
Prepaid expenses and other current assets
6,705
-5,930
5,177
70
Operating lease right-of-use assets
0
0
0
-3,814
Other non-current assets
-48
-94
-334
38
Accounts payable
-
-
-2,992
-
Accounts payable, accrued expenses and other current liabilities
3,944
-11,601
-6,615
16,991
Deferred revenue
-3,032
-2,606
-5,184
-27,209
Operating lease liabilities, current and non-current
-5,748
-4,995
-9,139
-18,793
Other non-current liabilities
-5,366
-758
7,004
4,459
Net cash used in operating activities - continuing operations
-42,173
-46,433
-
-
Net cash used in operating activities - discontinued operations
-2,100
-253
-
-
Net cash used in operating activities - continuing operations
-44,273
-46,686
-47,678
-123,381
Deconsolidation of subsidiaries - cash
-
-
0
-
Purchases of marketable debt securities
44,284
83,161
16,792
401,838
Business acquisitions, net of cash acquired
-
-
0
0
Maturities of marketable debt securities
57,990
108,178
85,884
73,599
Purchases of notes receivable
-
-
0
-
Proceeds from sale of marketable debt securities
-
-
25,899
0
Proceeds from sales of marketable equity securities
-
-
0
-
Proceeds from sale of equipment
-
-
574
0
Purchases of property and equipment
2,619
1,933
5
7,660
Other
0
-48
461
-511
Net cash provided by (used in) investing activities
11,087
23,132
95,099
-335,388
Proceeds from atm offering
17,049
-
9,152
10,317
Payment of issuance costs related to atm offering
560
-
985
355
Proceeds from exercise of stock options
-
-
0
0
Taxes paid related to net share settlement of equity awards
-
-
0
-
Principal payments on finance leases
0
19
25
329
Contingent consideration payment
-
-
0
0
Other
-
-
-
0
Payment of equity issuance costs and other
-
-
0
-
Net cash provided by (used in) financing activities
16,489
-19
8,142
9,633
Effect of foreign exchange rates on cash and cash equivalents
43
-129
-152
353
Net decrease in cash, cash equivalents and restricted cash
-16,654
-23,702
55,411
-448,783
Cash and cash equivalents, beginning of period
167,202
-
-
-
Restricted cash, beginning of period
45,169
-
-
-
Cash, cash equivalents and restricted cash, beginning of period
156,960
-
-
605,743
Cash and cash equivalents, end of period
84,535
-
-
-
Restricted cash, end of period
87,480
-
-
-
Cash, cash equivalents and restricted cash, end of period
172,015
-
-
156,960
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from atm
offering
$17,049K
Maturities of marketable
debt securities
$57,990K
Net cash provided by
(used in) financing...
$16,489K
Net cash provided by
(used in) investing...
$11,087K
Effect of foreign
exchange rates on cash and...
$43K
Canceled cashflow
$560K
Canceled cashflow
$46,903K
Net decrease in
cash, cash...
-$16,654K
Canceled cashflow
$27,619K
Payment of issuance
costs related to atm...
$560K
Purchases of marketable
debt securities
$44,284K
Purchases of property and
equipment
$2,619K
Net cash used in
operating activities -...
-$44,273K
Depreciation and
amortization
$12,315K
Stock-based compensation
$7,595K
Non-cash lease expense
$6,143K
Loss on equity method
investment
-$4,673K
Accounts payable,
accrued expenses and...
$3,944K
Changes in operating
assets and liabilities
-$3,713K
Other non-current
assets
-$48K
Accretion of discount on
marketable securities
-$29K
Net cash used in
operating activities -...
-$42,173K
Net cash used in
operating activities -...
-$2,100K
Canceled cashflow
$38,460K
Net loss from
continuing operations
-$57,321K
Prepaid expenses and
other current assets
$6,705K
Operating lease
liabilities, current and...
-$5,748K
Other non-current
liabilities
-$5,366K
Deferred revenue
-$3,032K
(gain) loss on
investments
$1,987K
Other non-cash
activity
$474K
Buy us a coffee
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)